Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma-Reference-Cited by-同舟云学术

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma

Published:2019-05-07 Issue:10 Volume:145 Page:2792-2803
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Steins Anne¹²^ORCID,Ebbing Eva A.¹²,Creemers Aafke¹²^ORCID,Zalm Amber P.¹²,Jibodh Rajni A.¹,Waasdorp Cynthia¹,Meijer Sybren L.³,Delden Otto M.⁴,Krishnadath Kausilia K.⁵,Hulshof Maarten C.C.M.⁶,Bennink Roelof J.⁴,Punt Cornelis J.A.²,Medema Jan Paul¹⁷,Bijlsma Maarten F.¹⁷^ORCID,Laarhoven Hanneke W.M.²

Affiliation:

1. Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center AmsterdamAmsterdam UMC, University of Amsterdam Amsterdam The Netherlands

2. Department of Medical OncologyCancer Center Amsterdam, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

3. Department of PathologyCancer Center Amsterdam, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

4. Department of Radiology and Nuclear MedicineAmsterdam UMC, University of Amsterdam Amsterdam The Netherlands

5. Department of Gastroenterology and HepatologyAmsterdam UMC, University of Amsterdam Amsterdam The Netherlands

6. Department of RadiotherapyAmsterdam UMC, University of Amsterdam Amsterdam The Netherlands

7. Oncode Institute, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

Funder

KWF Kankerbestrijding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32364

Reference49 articles.

1. Evolution of acquired resistance to anti-cancer therapy

2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

3. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

4. Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

5. MicroRNA‐17 is downregulated in esophageal adenocarcinoma cancer stem‐like cells and promotes a radioresistant phenotype;Lynam‐Lennon N;Oncotarget,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

2. The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma;Communications Medicine;2024-05-17

3. NSG1 promotes glycolytic metabolism to enhance Esophageal squamous cell carcinoma EMT process by upregulating TGF-β;Cell Death Discovery;2023-10-23

4. Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition;OncoImmunology;2023-07-17

5. Local irradiation of patient-derived tumors in immunodeficient mice;STAR Protocols;2023-03